Kinetics of Enzyme Action: Essential Principles for Drug Hunters

Kinetics of Enzyme Action: Essential Principles for Drug Hunters

Volumn , Issue , 2011, Pages

  Stein, Ross L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84891584629     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118084410     Document Type: Book

References (220)

1. Moore, J. W. and R. G. Pearson (1981). Kinetics and Mechanism. New York, John Wiley & Sons.
2. Wilhelmy, L. (1850)." The law by which the action of acid on cane sugar occurs. " Ann. Phys. Chem. 81: 413-433.
3. Bartlett, P. A. and C. K. Marlowe (1983). " Phosphonamidates as transition-state analogue inhibitors of thermolysin. " Biochemistry 22 (20): 4618-4624.
4. Fischer, E. (1894)." Einfl uss der Confi guration aur de Wirkung Derenzyme. " Berichte Deutschen Chemischen Gesellschaft 27: 2985-2993.
5. Kline, P. C. and V. L. Schramm (1993). " Purine nucleoside phosphorylase. Catalytic mechanism and transition-state analysis of the arsenolysis reaction. " Biochemistry 32 (48): 13212-13219.
6. Maggiora, G. M. and R. L. Schowen (1977). The interplay of theory and experiment in bioorganic chemistry-Three case histories. In Bioorganic Chemistry, Vol. 1, E. E. van Tamelen, ed. New York, Academic Press.
7. Miles, R. W., et al. (1998)." One-third-the-sites transition-state inhibitors for purine nucleoside phosphorylase. " Biochemistry 37 (24): 8615-8621.
8. Miller, B. G. and R. Wolfenden (2002). " Catalytic profi ciency: The unusual case of OMP decarboxylase. " Annu. Rev. Biochem. 71: 847-885.
9. Pauling, L. (1946)." Molecular architecture and biological reactions. " Chem. Eng. News 24: 1375-1377.
10. Pauling, L. (1948)." The nature of forces between large molecules of biological interest. " Proc. R Inst. GB 34: 181-187.
11. Radzicka, A. and R. Wolfenden (1995). " Transition state and multisubstrate analogs. " Methods Enzymol. 249: 284-312.
12. Schowen, R. L. (1978). Catalytic power and transition state stabilization. In Transition States of Biochemical Processes, R. D. Gandour and R. L. Schowen, eds. New York, Plenum Press: 77-144.
13. Schramm, V. L. (2007)." Enzymatic transition state theory and transition state analogue design. " J. Biol. Chem. 282 (39): 28297-28300.
14. Stein, R. L. (2002)." Enzymatic hydrolysis of p-nitroacetanilide: Mechanistic studies of the aryl acylamidase from pseudomonas fl uorescens. " Biochemistry 41: 991-1000.
15. Stein, R. L. and E. H. Cordes (1981). " Kinetic α-deuterium isotope effects for E. coli purine nucleoside phosphorylase catalyzed phosphorolysis of adenosine and inosine. " J. Biol. Chem. 256: 767-772.
16. Stein, R. L., et al. (1984)." Transition-state structural features for anilide hydrolysis from β-deuterium isotope effects. " J. Am. Chem. Soc. 106: 1457-1461.
17. Stein, R. L., et al. (1978)." A Kinetic α-deuterium isotope effect for the binding of purine nucleosides to calf spleen purine nucleoside phosphorylase. Evidence for catalysis by distortion. " J. Am. Chem. Soc. 100: 6249-6251.
18. Stein, R. L., et al. (1987)." Mechanism of slow-binding inhibition of human leukocyte elastase by trifl uormethyl ketones. " Biochemistry 26: 2682-2689.
19. Wolfenden, R. (1969)." Transition state ananogues for enzyme catalysis. " Nature 223: 704-705.
20. Wolfenden, R. (1972a). " Analog approaches to the structure of the transition state in enzyme reactions. " Acc. Chem. Res. 5: 10-18.
21. Case, A., et al. (2005)." Development of a mechanism-based assay for tissue transglutaminase-Results of a high-throughput screen and discovery of inhibitors. " Anal. Biochem. 338: 237-244.
22. Antoniou, D., et al. (2002)." Barrier passage and protein dynamics in enzymatically catalyzed reactions. " Eur. J. Biochem. 269: 3102-3112.
23. Armstrong, E. F. (1904)." Studies on enzyme action. III. The infl uence of the products of change on the rate of change by sucroclastic enzymes. " Proc. Roy. Soc. 73: 516.
24. Banerjee, S. K., et al. (1975)." Reaction of N-acetylglucosamine oligosaccharides with lysozyme. Temperature, pH, and solvent deuterium isotope effects; equilbrium, steady state, and pre-steady state measurements. " J. Biol. Chem. 250 (11): 4355-4367.
25. Berzelius, J. J. (1836)." Einige Ideen uber eine bei der Bildung Organischer Verbindungen in der lebenden Natur wirksame, aber bisher nicht bemerkte Kraft [A few ideas about a force active in the formation of organic compounds in living nature but hitherto not oberserved]. " Jahres-Bericht uber die Fortschritte Physischen Wissenschaften 237: 237-248.
26. Brown, A. (1902)." Enzyme action. " J. Chem. Soc. 81: 377-388.
27. Buchner, E. (1897)." Alcoholic fermentation without yeast cells. " Ber. Chem. Ges. 30: 117.
28. Bugg, T. D. H. (2001)." The development of mechanistic enyzmology in the 20th century. " Nat. Prod. Rep. 18: 465-493.
29. Careri, G., et al. (1979)." Enzyme dynamics: The statistical physics approach. " Annu. Rev. Biophys. Bioeng. 8: 69-97.
30. Case, A. and R. L. Stein (2003). " Mechanistic origins of the substrate selectivity of serine proteases. " Biochemistry 42: 3335-3348.
31. Cleland, W.W. (1963a). " The kinetics of enzyme catalyzed reactions with two or more substrates or products. I. Nomenclature and rate equations. " Biochim. Biophys. Acta 67: 104-137.
32. Cleland, W.W. (1963b). " The kinetics of enzyme catalyzed reactions with two or more substrates or products. II. Inhibition: nomenclature and theory. " Biochim. Biophys. Acta 67: 173-187.
33. Cleland, W.W. (1963c). " The kinetics of enzyme catalyzed reactions with two or more substrates or products. III. Prediction of initial velocity and inhibition patters by inspection. " Biochim. Biophys. Acta 67: 188-196.
34. Cleland, W.W. (1963d). " Computer programmes for processing enzyme kinetic data. " Nature 198: 463-465.
35. Cook, P. F. (1991). Enzyme Mechanism from Isotope Effects. New York, CRC Press.
36. Coombs, H. I. (1927)." Studies on xanthine oxidase. The specifi city of the system. " Biochem. J. 21: 1260-1265.
37. Dahlquist, F. W., et al. (1969)." Application of secondary alpha-deuterium kinetic isotope effects to studies of enzyme catalysis. Glycoside hydrolysis by lysozyme and beta-glucosidase. " Biochemistry 8 (10): 4214-4221.
38. Dakin, H. D. (1903)." The hydrolysis of optically inactive esters by means of enzymes. " J. Physiol. 30: 253-263.
39. Dixon, M. and S. Thurlow (1924). " Studies on xanthine oxidase. " Biochem. J. 18 (976-988): 976-988.
40. Elrod, J. P., et al. (1976)." Proton bridges in enzyme catalysis. " Faraday Symp. Chem. Soc. 10: 145-153.
41. Elrod, J. P., et al. (1980)." Protonic reorganization and substrate structure in catalysis by serine proteases. " J. Am. Chem. Soc. 102: 3917-3922.
42. Eyring, H. (1935a). " The activated complex and the absolute rates of chemical reactions. " Chem. Rev. 17: 65-77.
43. Eyring, H. (1935b). " The activated complex in chemical reactions. " J. Phys. Chem. 3: 107-115.
44. Falk, K. G. (1918)." A chemical study of enzyme action. " Science 47: 423-429.
45. Fersht, A. R. (1999). Structure and Mechanims in Protein Science-A Guide to Enzyme Catalysis and Protein Folding. New York, W.H. Freeman and Co. Fischer, E. (1894). " Infl uence of the confi guration on the activity of the enzyme. " Ber. Chem. Ges. 27: 2985.
46. Gutfreund, H. (1975). Enzymes: Physical Principles. New York, John Wiley & Sons.
47. Hay, S., et al. (2008). " Atomistic insight into the origin of the temperature-dependence of kinetic isotope effects and H-tunnelling in enzyme systems is revealed through combined experimental studies and biomolecular simulation. " Biochem. Soc. Trans. 36 (Pt 1): 16-21.
48. Hengge, A. C. and R. L. Stein (2004). " Role of protein conformational mobility in enzyme catalysis: Acylation of α-chymotrypsin by specifi c peptide substrates. " Biochemistry 43 (3): 742-747.
49. Hofmeister, F. (1902)." On the structure and grouping of the protein molecule. " Ergeb. Physiol. 1: 759.
50. Hunter, F. E. and O. H. Lowry (1955). " The effects of drugs on enzyme systems. " Pharmacol. Rev. 7: 89-135.
51. Jenks, W. P. (1975)." Binding energy, specifi city, and enzymatic catalysis: the Circe effect. " Adv. Enzymol. Relat. Areas Mol. Biol. 43: 219-410.
52. Johnson, L. N. and D. C. Phillips (1965). " Structure of some crystalline lysozyme-inhibitor complexes determined by X-ray analysis at 6 Angstrom resolution. " Nature 206: 761-762.
53. Kastle, J. H. (1901)." On the vital activity of the enzymes. " Science 13: 765-771.
54. Knapp, M. J. and J. P. Klinman (2002). " Environmentally coupled hydrogen tunneling-Linking catalysis to dynamics. " Eur. J. Biochem. 269: 3113-3121.
55. Kuhne, W. (1877)." Ueber das Verhalten Verschiedener Organisirter und Sog Ungeformter Fermente [On the behavior of different organized and so-called unformed ferments]. " Verhandlungen des Naturehistorisch-Medicinischen Vereins 1: 190.
56. Levene, P. A. T. (1905)." The cleavage products of proteoses." J. Biol. Chem. 1: 45-58.
57. Loew, O. (1899)." On the chemical nature of enzymes. " Science 10: 955-961.
58. Lumry, R. and R. Biltonen (1969). " Thermodynamic and kinetic aspects of protein conformations in relation to physiological function. " In Structure and Stability of Biological Macromolecules, S. Timasheff and G. Fasman, eds. New York, Marcel Dekker.
59. Mahler, H. R. and J. Douglas (1957). " Mechanisms of enzyme-catalyzed oxidation-reduction reactions. I. An investigation of the yeast alcohol dehydrogenase reaction by means of the isotope rate effect. " J. Am. Chem. Soc. 79: 1159-1166.
60. Matthews, B. W., et al. (1967)." Three-dimensional structure of tosyl-alpha-chymotrypsin. " Nature 214: 652-656.
61. Michaelis, L. and M. Menten (1913). " The kinetics of invertase action. " Biochem. Z. 49: 333.
62. Northrop, D. B. (1981)." The expression of isotope effects on enzyme-catalyzed reactions. " Annu. Rev. Biochem. 50: 103-131.
63. Ostwald, W. F. (1894)." Abstract on catalysis. " Zeitschrift Physikalische Chemie 15: 705-706.
64. Pauling, L. (1946)." Molecular architecture and biological reactions. " Chem. Eng. News 24: 1375-1377.
65. Pauling, L. (1948)." The nature of forces between large molecules of biological interest. " Proc. R Inst. G B 34: 181-187.
66. Prout, W. (1827)." On the ultimate composition of simple alimentary substances; with some preliminary remarks on the analysis of organized bodies in general. " Philos. Trans. R Soc. 117: 355-388.
67. Quinn, D. M., et al. (1980)." Protonic reorganization in catalysis by serine proteases: Acylation by small substrates. " J. Am. Chem. Soc. 102: 5358-5365.
68. Schowen, R. L. (1978). Catalytic power and transition-state stabilization. In Transition States of Biochemical Processes, R. D. Gandour and R. L. Schowen, eds. New York, Plenum Press: 77-114.
69. Seltzer, S., et al. (1959)." Isotope effects in the enzymatic decarboxylation of oxalacetic acid. " J. Am. Chem. Soc. 81: 4018-4024.
70. Sizer, I. W. (1957)." Chemical aspects of enzyme inhibition. " Science 125: 54-59.
71. Somogyi, B., et al. (1984)." The dynamic basis of energy transduction in enzymes. " Biochim. Biophys. Acta 768: 81-112.
72. Stein, R. L., et al. (1987)." Catalysis by human leukocyte elastase. 7. Proton inventory as a mechanistic probe. " Biochemistry 26: 1305-1314.
73. Traube, M. (1858a). " On the theory of fermentation and decay. " Ann. Physiol. 103: 331.
74. Traube, M. (1858b). " On the theory of fermentation and decay phenomena, also of ferment activity in general. " Annalen Physik Chemie 103: 331.
75. Welch, G. R. (1986). The Fluctuating Enzyme. New York, John Wiley & Sons.
76. Welch, G. R., et al. (1982)." The role of protein fl uctuations in enzyme action: A review. " Prog. Biophys. Mol. Biol. 39: 109-146.
77. Wilhelmy, L. (1850)." The law by which the action of acid on cane sugar occurs. " Annalen Physik Chemie 81: 413-433.
78. Wolfenden, R. (1969)." Transition state analogues for enzyme catalysis. " Nature 223 (5207): 704-705.
79. Woods, D. D. (1950)." Biochemical signifi cance of the competition between p-Aminobenzoic acid and the sulphonamides. " Ann. N Y Acad. Sci. 52: 1199-1211.
80. Woolf, B. (1931)." The addition compound theory of enzyme action. " Biochem. J. 25: 342-348.
81. Wynne-Jones, W. F. K. and H. Eyring (1935). " The absolute rate of reactions in condensed phases. " J. Chem. Phys. 3: 492-402.
82. Bodenstein, M. (1913)." Zur Kinetik des Chlorknallgases. " Z. Phys. Chem. 85: 329.
83. Briggs, G. E. and J. B. S. Haldane (1925). " A note on the kinetics of enzyme action. " Biochem. J. 19: 338-339.
84. Brown, A. (1902)." Enzyme action. " J. Chem. Soc. 81: 377-388.
85. Frieden, C. (1979)." Slow transactions and hysteretic behavior in enzymes. " Annu. Rev. Biochem. 48: 471-489.
86. Good, N. E., et al. (1966)." Hydrghen ion buffers for biological research. " Biochemistry 5: 467-477.
87. Harrison, R. K., et al. (1989)." A semi-continuous, HPLC-based assay for stromelysin. " Anal. Biochem. 80: 110-113.
88. Michaelis, L. and M. Menten (1913). " The kinetics of invertase action. " Biochem. Z. 49: 333.
89. Neet, K. E. and G. R. Ainslie (1980). " Hysteretic enzymes." Methods Enzymol. 64: 192-226.
90. Niedzwiecki, L., et al. (1992)." Substrate specifi city of the human matrix metalloproteinase stromelysin and the development of continuous fl uorometric assays. " Biochemistry 31: 12618-12623.
91. Schowen, R. L. (1978). Catalytic power and transition-state stabilization. In Transition States of Biochemical Processes, R. D. Gandour and R. L. Schowen, eds. New York, Plenum Press: 77-114.
92. Segel, I. H. (1975). Enzyme Kinetics. New York, John Wiley & Sons.
93. Wilhelmy, L. (1850)." The law by which the action of acid on cane sugar occurs. " Annalen Physik Chemie 81: 413-433.
94. Arrhenius, S. (1889)." On the reaction velocity of the inversion of cane sugar by acids. " J. Phys. Chem. 4: 226-238.
95. Bardsley, W. G., P. Leff, J. Kavanagh, and R. D. Waight (1980). " Deviations from Michaelis-Menten kinetics. " Biochem. J. 187: 739-765.
96. Eyring, H. (1935a). " The activated complex and the absolute rates of chemical reactions. " Chem. Rev. 17: 65-77.
97. Eyring, H. (1935b). " The activated complex in chemical reactions. " J. Phys. Chem. 3: 107-115.
98. Glasstone, S., K. J. Laidler, and H. Eyring (1941). The Theory of Rate Processes. New York, McGraw-Hill.
99. Hill, C. M., R. D. Waight, and W. G. Bardsley (1977). " Does any enzyme follow the Michaelis-Menten equation? " Mol. Cell. Biochem. 15: 173-178.
100. Neet, K. E. and G. R. Ainslie (1980). " Hysteretic enzymes." Methods Enzymol. 64: 192-226.
101. Richard, J., J. C. Meunier, and J. Buc (1974). " Regulatory behavior of monomeric enzymes 1. The mnemonical enzyme concept. " Eur. J. Biochem. 49: 195-208.
102. Segel, I. H. (1975). Enzyme Kinetics. New York, John Wiley & Sons.
103. Tomlinson, S. M. and S. J. Watowich (2008). " Substrate inhibition kinetic model for West Nile virus NS2B-NS3 protease. " Biochemistry 47: 11763-11770.
104. Whitehead, E. P. (1976)." Simplifi cations of the derivation and forms of steady-state equations for non-equilibrium random, substrate-modifi er, and allosteric enzyme mechanisms. " Biochem. J. 159: 449-456.
105. Wynne-Jones, W. F. K. and H. Eyring (1935). " The absolute rate of reactions in condensed phases. " J. Chem. Phys. 3: 492-402
106. Barendrecht, H. F. (1913)." Enzyme-action, facts and theory. " Biochem. J. 7: 549-561.
107. Bergamini, C. M. (1988)." GTP modulates calcium binding and cation-induced conformational changes in erythrocyte transglutaminase. " FEBS Lett. 239: 255-258.
108. Brown, A. (1902)." Enzyme action. " J. Chem. Soc. 81: 377-388.
109. Case, A., et al. (2005)." Development of a mechanism-based assay for tissue transglutaminase-Results of a high-throughput screen and discovery of inhibitors. " Anal. Biochem. 338: 237-244.
110. Case, A. and R. L. Stein (2003). " Kinetic analysis of the action of tissue transglutaminase on peptide and protein substrates. " Biochemistry 42: 9466-9481.
111. Coombs, H. I. (1927)." Studies on xanthine oxidase. The specifi city of the system. " Biochem. J. 21: 1260-1265.
112. de Cristofaro, T., et al. (1999)." The length of polyglutamine tact, its level of expression, the rate of degradation, and the transglutaminase activity infl uence the formation of intracellular aggregates. " Biochem. Biophys. Res. Commun. 260: 150-158.
113. Dixon, M. and S. Thurlow (1924). " Studies on xanthine oxidase. " Biochem. J. 18 (976-988): 976-988.
114. Folk, J. E. (1983)." Mechanism and basis for specifi city of transglutaminase-catalyzed ε-(γ-glutamyl)lysine bond formation. " Adv. Enzymol. Relat. Areas Mol. Biol. 54: 1-56.
115. Folk, J. E. and S. Chung (1985). " Transglutaminases. " Methods Enzymol. 113: 358-375.
116. Gentile, V., et al. (1998)." Tissue transglutaminase-catalyzed formation of high-molecular-weight aggregates in vitro is favored with long polyglutamine domains. " Arch. Biochem. Biophys. 352: 314-321.
117. Hibi, K., et al. (1999)." PGP9.5 as a candidate tumor marker for non-small-cell lung cancer. " Am. J. Pathol. 155 (3): 711-715.
118. Iismaa, S., et al. (2000)." GTP binding and signaling by G h /transglutaminase II involves distinct residues in a unique GTP-binding pocket. " J. Biol. Chem. 275: 18259-18265.
119. Junn, E., et al. (2003)." Tissue transglutaminase-induced aggregation of α-synuclein: Implications for Lewy body formation in Parkinson ' s disease and dementia with Lewy bodies. " Proc. Natl. Acad. Sci. 100: 2047-2052.
120. Leroy, E., et al. (1998)." The ubiquitin pathway in Parkinson ' s disease. " Nature 395: 451-452.
121. Lowe, J., et al. (1990)." Ubiquitin carboxyl-terminal hydrolase (PGP9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases. " J. Pathol. 161: 153-160.
122. Maraganore, D. M., et al. (2004)." UCHL1 is a Parkinson ' s disease susceptibility gene. " Ann. Neurol. 55 (4): 512-521.
123. Mermerian, A., et al. (2007)." Structure-activity relationship, kinetic mechanism, and selectivity for a new class of ubiquitin C-terminal hydrolase-L1 inhibitors. " Bioorg. Med. Chem. Lett. 17: 3729-3732.
124. Quastel, J. H. and W. R. Wooldridge (1928). " Some properties of the dehydrogenating enzymes of bacteria. " Biochem. J. 22: 689-702.
125. Stein, R. L. (2003)." A new model for drug discovery-Meeting our societal obligations. " Drug Discov. Today 8: 245-248.
126. Stein, R. L. (2004)." High-throughput screening in academia: The Harvard experience. " J. Biomol. Screen. 8: 615-619.
127. Tezel, E., et al. (2000)." PGP9.5 as a prognostic factor in pancreatic cancer. " Clin. Cancer Res. 6 (12): 4764-4767.
128. Venere, A. D., et al. (2000)." Opposite effects of Ca2 + and GTP calcium binding on tissue transglutaminase tertiary structure. " J. Biochem. 275: 3915-3932.
129. Yamazaki, T., et al. (2002)." PGP9.5 as a marker for invasive colorectal cancer. " Clin. Cancer Res. 8 (1): 192-195.
130. Berman, H. A. and K. Leonard (1991). " Interaction of tetrahydroaminoacridine with acetylcholinesterase and butyrylcholinesterase. " Mol. Pharmacol. 41: 412-418.
131. Cochran, J. C. and S. P. Gilbert (2005). " ATPase mechanism of Eg5 in the absence of microtubules. " Biochemistry 44: 16633-16648.
132. Jia, Y., et al. (2006)." Comparative analysis of various in vitro COT kinase assay formats and their applications in inhibitor identifi cation and characterization. " Anal. Biochem. 350: 268-276.
133. Krysiak, T. C. and S. P. Gilbert (2006). " Dimeric Eg5 maintains processivity through alternating-site catalysis with rate-limiting ATP hydrolysis. " J. Biol. Chem. 281: 39444-39454.
134. Liu, M., et al. (2008)." Kinetic studies of Cdk5/p25 kinase: Phosphorylation of tau and complex inhibition by two prototype inhibitors. " Biochemistry 47: 8367-8377.
135. Rickert, K. W., et al. (2008)." Discovery and biochemical characterization of selective ATP competitive inhibitors of the human mitotic kinesin KSP. " Arch. Biochem. Biophys. 469: 220-231.
136. Schowen, R. L. (1978). Catalytic power and transition state stabilization. In Transition States of Biochemical Processes, R. D. Gandour and R. L. Schowen, eds. New York, Plenum Press: 77-144.
137. Stein, R. L. (1985)." Catalysis by human leukocyte elastase. 5. Structural features of the virtual transition state for acylation. " J. Am. Chem. Soc. 107 (25): 7768-7769.
138. Bull, H. G., M. Garcia-Calvo, S. Andersson, W. Baginsky, H. K. Chan, D. E. Ellsworth, R. R. Miller, R. A. Sterns, R. K. Bakshi, G. R. Rasmussen, R. L. Tolman, R. W. Myers, J. W. Kozarich, and G. S. Harris(1996). " Mechanism-based inhibition of human 5 α-reductase by fi nasteide. " J. Am. Chem. Soc. 118: 2359-2365.
139. Case, A. and R. L. Stein (2003). " Kinetic analysis of the action of tissue transglutaminase on peptide and protein substrates. " Biochemistry 42: 9466-9481.
140. Case, A. and R. L. Stein (2005). " Mechanistic studies of the interaction of tissue transglutaminase with a novel, non-peptidic slow-binding inhibitor. " Biochemistry 46: 1106-1115.
141. Case, A. and R. L. Stein (2006). " Mechanistic studies of ubiquitin C-terminal hydrolase L1. " Biochemistry 45: 2443-2452.
142. Case, A., J. Ni, L.-A. Yeh, and R. L. Stein (2005). " Development of a mechanism-based assay for tissue transglutaminase-Results of a high-throughput screen and discovery of inhibitors. " Anal. Biochem. 338: 237-244.
143. Feinstein, G., C. J. Malemud, and A. Janoff (1976). " The inhibition of human leukocyte elastase and chymotrypsin-like protease by elastatinal and chymostatin. " Biochim. Biophys. Acta 429: 925-932.
144. Harding, M. W., A. Galat, D. E. Uehling, and S. L. Schreiber (1989). " A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase. " Nature 341: 758-760.
145. Harrison, R. K. and R. L. Stein (1992). " Mechanistic studies of enzymatic and nonenzymatic prolyl cis-trans isomerization. " J. Am. Chem. Soc. 114: 3464-3471.
146. Rasmusson, G., G. F. Reynolds, N. G. Steinberb, E. Walton, G. Patel, T. Liang, M. A. Cascieri, A. H. Cheung, J. R. Brooks, and C. Berman (1986). " Azasteroids: Structure-activity relationships for inhibition of 5 α-reductase and of androgen receptor binding. " J. Med. Chem. 29: 2298-2315.
147. Stein, R. L. (1991)." Exploring the catalytic activity of immunophilins. " Curr. Biol. 1: 234-236.
148. Stein, R. L. (1993)." Mechanisms of enzymic and non-enzymic prolyl isomerization. " Adv. Protein Chem. 44: 1-24.
149. Stein, R. L. and A. M. Strimpler (1987). " Slow-binding inhibition of chymotrypsin and cathepsin G by the peptide aldehyde chymostatin. " Biochemistry 26 (9): 2611-2615.
150. Stein, R. L. and D. A. Trainor (1986). " Mechanism of inactivation of human leukocyte elastase by a chloromethyl ketone: Kinetic and solvent isotope effect studies. " Biochemistry 25 (19): 5414-5419.
151. Stein, R. L., A. M. Strimpler, P. D. Edwards, J. J. Lewis, R. C. Mauger, J. A. Schwartz, M. A. Stein, and D. A. Trainor (1987). " Mechanism of slow-binding inhibition of human leukocyte elastase by trifl uoromethyl ketones. " Biochemistry 26: 2682-2689.
152. Stein, R. L., C. DeCicco, and B. Thomas (2001). " Slow-binding inhibition of γ-glutamyl transpeptidase by γ-boroGlu. " Biochemistry 40: 5804-5811.
153. Umezawa, H., Y. Aoyagi, H. Morishma, S. Kunimoto, and M. Matsuzari (1970). " Chymostatin, a new chymotrypsin inhibitor produced by acinomycetes. " J. Antibiot. 23: 425-427.
154. Case, A. and R. L. Stein (2003). " Kinetic analysis of the action of tissue transglutaminase on peptide and protein substrates. " Biochemistry 42: 9466-9481.
155. Liu, M., et al. (2008)." Kinetic studies of Cdk5/p25 kinase: Phosphorylation of tau and complex inhibition by two prototype inhibitors. " Biochemistry 47: 8367-8377.
156. Robertson, J. G. (2005)." Mechanistic basis of enzyme-targeted drugs. " Biochemistry 44: 5561-5571.
157. Segel, I. H. (1975). Enzyme Kinetics. New York, John Wiley & Sons.
158. Stein, R. L., et al. (2001)." Slow-binding inhibition of γ-glutamyl transpeptidase by γ-boroGlu. " Biochemistry 40: 5804-5811.
159. Baur, J. A. (2010)." Resveratrol, sirtuins, and the promise of a DR mimetic. " Mech. Ageing Dev. 131: 261-269.
160. Guarente, L. (2007)." Sirtuins in aging and disease. " Cold Spring Harb. Symp. Quant. Biol. 72: 483-488.
161. Haigis, M. C. and D. Sinclair (2010). " Mammalian sirtuins: Biological insights and disease relevance. " Annu. Rev. Pathol. 5: 253-259.
162. Liu, M., et al. (2008)." Kinetic studies of Cdk5/p25 kinase: Phosphorylation of tau and complex inhibition by two prototype inhibitors. " Biochemistry 47: 8367-8377.
163. Roskoski, R. (2003)." STI-571: An anticancer protein-tyrosine kinase inhibitor. " Biochem. Biophys. Res. Commun. 309: 709-717.
164. Sauve, A. A., et al. (2001)." Chemistry of gene silencing: The mechanism of NAD-dependent deacetylation reactions. " Biochemistry 40: 15456-15463.
165. Sauve, A. A. and V. L. Schramm (2003). " Sir2 regulation by nicotinamide results from switching between base exchange and deacetylation chemistry. " Biochemistry 42: 9249-9256.
166. Sauve, A. A., et al. (2006)." The biochemistry of sirtuins. " Annu. Rev. Biochem. 75: 435-465.
167. Smith, B. C. and J. M. Denu (2007). " Mechanism-based inhibition of Sir2 deacetylases by thioacetyl-lysine peptine. " Biochemistry 46: 14478-14486.
168. Bertalanffy, L. V. (1968). General Systems Theory-Foundations, Development, Applications. New York, George Braziller.
169. Boboyevitch, M. A. and D. P. Fairlie (2007). " A new paradigm for protein kinase inhibition: Blocking phosphorylation without directly targeting ATP binding. " Drug Discov. Today 12: 622-633.
170. Cabrol, C., et al. (2009)." Small molecule activators of insulin degrading enzyme. " PLoS ONE 4: e5274.
171. Cori, G. T., et al. (1938)." The action of nucleotides in the disruptive phosphorylation of glycogen. " J. Biol. Chem. 123: 381-389.
172. Dai, H., et al. (2010)." SIRT1 activation by small molecules-Kinetic and biophysical evidence for direct interaction of enzyme and activator. " J. Biol. Chem. 285: 32695-32703.
173. Dennis, M. S., et al. (2001)." Selection and characterization of a new class of peptide exosite inhibitors of coagulation factor VIIa. " Biochemistry 40: 9513-9521.
174. Eliasson, R., et al. (1994)." Allosteric control of the substrate specifi city of the anaerobic ribonucleotide reductase from Escherichia coli. " J. Biol. Chem. 269: 26052-26057.
175. Hardy, J. A. and J. A. Wells (2004). " Searching for new allosteric sites in enzymes. " Curr. Opin. Chem. Biol. 14: 706-715.
176. Hauske, P., et al. (2008)." Allosteric regulation of proteases. " Chembiochem 9: 2920-2928.
177. Howitz, K. T., et al. (2003)." Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. " Nature 425 (6954): 191-196.
178. Kaeberlein, M., T., et al. (2005)." Substrate-specifi c activation of sirtuins by resveratrop. " J. Biol. Chem. 280: 17038-17045.
179. Laszlo, E. (1972). Introduction to Systems Philosophy-Toward a New Paradigm of Contemporary Thought. New York, Harper & Row Publishers.
180. Lewis, J. A., et al. (2008)." Allosteric modulation of kinases and GPCRs: Design principles and structural diversity. " Curr. Opin. Chem. Biol. 12: 269-280.
181. Mentch, F., et al. (1987)." Transition state structures for N-glycoside hydrolysis of AMP by acid adn by AMP nucleosidase in the presence and absence of allosteric activator. " Bichemistry 26: 921-930.
182. Milne, J. C., et al. (2007)." Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. " Nature 450 (7170): 712-716.
183. Monad, J., et al. (1963)." Allosteric proteins and cellular control systems. " J. Mol. Biol. 6: 306-329.
184. Parkin, D. W. and V. L. Schramm (1987). " Catalytic and allosteric mechanism of AMP nucleosidase from primary, b-secondary, and multiple heavy atom kinetic isotope effects. " Biochemistry 26: 913-920.
185. Qiu, W. Q. and M. F. Folstein (2006). " Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer ' s disease: Review and hypothesis. " Neurobiol. Aging 27: 190-198.
186. Ralph, E. C., et al. (2008)." Glucose modulation of glucokinase activation by small molecules. " Biochemistry 47: 5028-5036.
187. Sauve, A. A., et al. (2006)." The biochemistry of sirtuins. " Annu. Rev. Biochem. 75: 435-465.
188. Schramm, V. L. (1974)." Kinetic properties of allosteric adenosine monophosphate nucleosidase from Azotobacter vinelandii. " J. Biol. Chem. 249: 1729-1736.
189. Segel, I. H. (1975).Enzyme Kinetics. New York, John Wiley & Sons.
190. Song, E. S., et al. (2004)." ATP effects on insulin-degrading enzyme are mediated primarily through its triphosphate moiety. " J. Biol. Chem. 279: 54216-54220.
191. Stein, R. L. (2006)." A process theory of enzyme catalytic power-The interplay of science and metaphysics. " Found. Chem. 8: 3-29.
192. Antoniou, D., et al. (2002)." Barrier passage and protein dynamics in enzymatically catalyzed reactions. " Eur. J. Biochem. 269: 3102-3112.
193. Bender, M. L. and J. V. Killgeffer (1973). " Chymotrypsins. " CRC Crit. Rev. Biochem. 1: 149-199.
194. Careri, G., et al. (1979)." Enzyme dynamics: The statistical physics approach. " Ann. Rev. Biophys. Bioeng. 8: 69-97.
195. Case, A. and R. L. Stein (2003). " Mechanistic origins of the substrate selectivity of serine proteases. " Biochemistry 42: 3335-3348.
196. Cook, P. F. and W. W. Cleland (2007). Enzyme Kinetics and Mechanism. London, Garland Science.
197. Cornish-Bowden, A. (2002)." Enthalpy-entropy compensation: A phantom phenomenon. " J. Biosci. 27: 121-126.
198. Gavish, B. (1980)." Position-dependent viscosity effects on rate constants. " Phys. Rev. Lett. 44: 1160.
199. Good, N. E., et al. (1966)." Hydrogen ion buffers for biological research. " Biochemistry 5: 467-477.
200. Hengge, A. C. and R. L. Stein (2004). " Role of protein conformational mobility in enzyme catalysis: Acylation of.alpha.-chymotrypsin by specifi c peptide substrates. " Biochemistry 43 (3): 742-747.
201. Knapp, M. J. and J. P. Klinman (2002). " Environmentally coupled hydrogen tunneling-Linking catalysis to dynamics. " Eur. J. Biochem. 269: 3113-3121.
202. Lumry, R. and R. Biltonen (1969). " Thermodynamics and kinetic aspects of protein conformations in relation to physiological functions. " In Structure and Stability of Biolo gical Macromolecules, S. Timasheff and G. Fasman, eds. New York, Dekker.
203. Quinn, D. M. and L. D. Sutton (1991). Solvent isotope in enzymic reactions. In Enzyme Mechanism from Isotope Effects, P. F. Cook, ed. Boston, MA, CRC Press: 73-126.
204. Schowen, K. B. J. (1978a). Solvent hydrogen isotope effects. In Transition States of Biochemical Processes, R. D. Gandour and R. L. Schowen, eds. New York, Plenum Press: 225-284.
205. Schowen, R. L. (1978b). Catalytic power and transition-state stabilization. In Transition States of Biochemical Processes, R. D. Gandour and R. L. Schowen, eds. New York, Plenum Press: 77-114.
206. Somogyi, B., et al. (1984)." The dynamic basis of energy transduction in enzymes. " Biochim. Biophys. Acta. 768: 81-112.
207. Stein, R. L. (1981)." Analysis of kinetic isotope effects on complex reactions utilizing the concept of the virtual transition state. " J. Org. Chem. 46: 3328-3330.
208. Stein, R. L. (1983)." Catalysis by human leukocyte elastase. 1. Substrate structural dependence of rate-limiting protolytic catalysis and operation of the charge relay system. " J. Am. Chem. Soc. 105 (15): 5111-5116.
209. Stein, R. L. (1985a). " Catalysis by human leukocyte elastase. 5. Structural features of the virtual transition state for acylation. " J. Am. Chem. Soc. 107 (25): 7768-7769.
210. Stein, R. L. (1985b). " Catalysis by human leukocyte elastase. 4. Role of secondary-subsite interactions. " J. Am. Chem. Soc. 107: 5767-5775.
211. Stein, R. L. (2002)." Enzymatic hydrolysis of p-nitroacetanilide: Mechanistic studies of the aryl acylamidase from pseudomonas fl uorescens. " Biochemistry 41: 991-1000.
212. Stein, R. L. (2007). Proton transfer during catalysis by hydrolases. In Hydrogen Transfer Reactions, Vol. 4, J. T., Hynes, J. P. Klinman, H. H. Limbach, and R. L. Schowen, eds. Weinheim: Wiley-VCH Verlag: 1455-1472.
213. Stein, R. L. and E. H. Cordes (1981). " Kinetic a-deuterium isotope effects for E. coli purine nucleoside phosphorylase-catalyzed phosphorolysis of adenosine and inosine. " J. Biol. Chem. 256: 767-772.
214. Stein, R. L., et al. (1987)." Catalysis by human leukocyte elastase. 7. Proton inventory as a mechanistic probe. " Biochemistry 26: 1305-1314.
215. Thomas, B., et al. (2001)." Kinetic and mechanistic studies of penicillin-binding protein 2x from Streptococcus pneumoniae. " Biochemistry 40: 15811-15823.
216. Vashishta, A. K., et al. (2009)." Chemical mechanism of saccaropine reductase from Saccharomyces cerevisiae. " Biochemistry 48: 5899-5907.
217. Venkatasubban, K. S. and R. L. Schowen (1984). " The proton inventory technique. " CRC Crit. Rev. Biochem. 17: 1-44.
218. Welch, G. R. (1986). The Fluctuating Enzyme. New York, John Wiley & Sons.
219. Welch, G. R., et al. (1982)." The role of protein fl uctuations in enzyme action: A review. " Prog. Biophys. Molec. Biol. 39: 109-146.
220. Zhou, J. and J. A. Adams (1997). " Is there a catalytic base in the active site of cAMP-dependent protein kinase? " Biochemistry 36: 2977-2984.